The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Anne-Marie Cleton-Jansen

Department of Pathology

Leiden University Medical Center

Albinusdreef 2




Name/email consistency: high



  • Department of Pathology, Leiden University Medical Center, Albinusdreef 2, Leiden, Netherlands. 2001 - 2013


  1. Mesenchymal stem cell transformation and sarcoma genesis. Xiao, W., Mohseny, A.B., Hogendoorn, P.C., Cleton-Jansen, A.M. Clin. Sarcoma. Res (2013) [Pubmed]
  2. Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways. Cleton-Jansen, A.M., Anninga, J.K., Briaire-de Bruijn, I.H., Romeo, S., Oosting, J., Egeler, R.M., Gelderblom, H., Taminiau, A.H., Hogendoorn, P.C. Br. J. Cancer (2009) [Pubmed]
  3. ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism. Cleton-Jansen, A.M., van Eijk, R., Lombaerts, M., Schmidt, M.K., Van't Veer, L.J., Philippo, K., Zimmerman, R.M., Peterse, J.L., Smit, V.T., van Wezel, T., Cornelisse, C.J. BMC. Cancer (2008) [Pubmed]
  4. Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma. Cleton-Jansen, A.M., van Beerendonk, H.M., Baelde, H.J., Bovée, J.V., Karperien, M., Hogendoorn, P.C. Clin. Cancer Res. (2005) [Pubmed]
  5. A distinct phenotype characterizes tumors from a putative genetic trait involving chondrosarcoma and breast cancer occurring in the same patient. Cleton-Jansen, A.M., Timmerman, M.C., van de Vijver, M.J., van Asperen, C.J., Kroon, H.M., Eilers, P.H., Hogendoorn, P.C. Lab. Invest. (2004) [Pubmed]
  6. Different mechanisms of chromosome 16 loss of heterozygosity in well- versus poorly differentiated ductal breast cancer. Cleton-Jansen, A.M., Buerger, H., Haar, N., Philippo, K., van de Vijver, M.J., Boecker, W., Smit, V.T., Cornelisse, C.J. Genes. Chromosomes. Cancer (2004) [Pubmed]
  7. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?. Cleton-Jansen, A.M. Breast Cancer Res. (2002) [Pubmed]
  8. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions. Cleton-Jansen, A.M., Callen, D.F., Seshadri, R., Goldup, S., Mccallum, B., Crawford, J., Powell, J.A., Settasatian, C., van Beerendonk, H., Moerland, E.W., Smit, V.T., Harris, W.H., Millis, R., Morgan, N.V., Barnes, D., Mathew, C.G., Cornelisse, C.J. Cancer Res. (2001) [Pubmed]
WikiGenes - Universities